Work

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.

Year: 1999

Type: article

Source: PubMed

Authors: M L Disis, K H Grabstein, P R Sleath, M A Cheever

Institutions: University of Washington, GlaxoSmithKline (United Kingdom)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: H2N PEPTIDE VACCINES--PATIENTS WI/H2N EXPRESSING CANCERS, T CELL IMMUNITY TO HUMAN BREAST CANCER, General Clinical Research Center

OpenAlex ID: W2164486810

FWCI: 10.04

Cites: 25

Cited by: 340

Related to: 10